Management of Duffy-Null Phenotype

Understanding the Duffy-Null Phenotype

The Duffy-null phenotype (Fy(a-b-)) results from a GATA mutation in the ACKR1 gene, which encodes Duffy antigens, and is particularly prevalent in individuals of African ancestry 1, 2, 3

Patients with the Duffy-null phenotype (Fy(a-b-)) who have a GATA mutation in the ACKR1 gene are not at risk for developing anti-Fyb antibodies and do not require Fyb-negative red cells for transfusion 1, 2, 3
Extended RBC antigen profiling should include Duffy antigens (Fya/Fyb) as part of comprehensive typing, particularly for patients who may require future transfusions 1, 2
For patients with sickle cell disease or other conditions requiring chronic transfusion, prophylactic matching for Rh (C, E or C/c, E/e) and K antigens is strongly recommended, with extended matching (including Jka/Jkb, Fya/Fyb, S/s) providing additional protection from alloimmunization 1, 2, 3

A normal WBC and normal ANC definitively excludes neutropenia (which would require ANC <1500/mm³) 4

Document the Duffy phenotype (Fy(a-b-)) in the patient's medical record for future transfusion planning 1, 2
Consider genotyping if the patient may require future transfusions, as genotyping provides more accurate antigen information than serology and is preferred for comprehensive blood typing 1, 2